Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development.
Viruses
; 15(4)2023 03 23.
Article
in En
| MEDLINE
| ID: mdl-37112794
ABSTRACT
Lately, the global incidence of flavivirus infection has been increasing dramatically and presents formidable challenges for public health systems around the world. Most clinically significant flaviviruses are mosquito-borne, such as the four serotypes of dengue virus, Zika virus, West Nile virus, Japanese encephalitis virus and yellow fever virus. Until now, no effective antiflaviviral drugs are available to fight flaviviral infection; thus, a highly immunogenic vaccine would be the most effective weapon to control the diseases. In recent years, flavivirus vaccine research has made major breakthroughs with several vaccine candidates showing encouraging results in preclinical and clinical trials. This review summarizes the current advancement, safety, efficacy, advantages and disadvantages of vaccines against mosquito-borne flaviviruses posing significant threats to human health.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Yellow Fever
/
Viral Vaccines
/
Flavivirus Infections
/
Dengue
/
Flavivirus
/
Zika Virus
/
Zika Virus Infection
/
Culicidae
Limits:
Animals
/
Humans
Language:
En
Journal:
Viruses
Year:
2023
Document type:
Article
Affiliation country:
China